The Annual Meeting is the foremost educational and scientific event for gynecologic oncologists Stenoparib has shown clinical benefit in heavily pre-treated patients, including those with ...
OS Therapies is a clinical stage oncology company focused on the identification, development, and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. OST-HER2, the Company's ...
Mitochondrial protonophores promote weight loss by increasing energy expenditure, a validated mechanism that complements incretin-based therapies. OrsoBio is advancing a portfolio of protonophores for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback